Author:
Brown Richard P.,Gerbarg Patricia L.
Reference97 articles.
1. Agency for Healthcare Research and Quality (AHRQ) (2007) S-adenosyl-l-methionine for treatment of depression, osteoarthritis, and liver disease. Summary, evidence report/technology assessment: number 64. AHRQ publication no. 02-E033, August 2002.
http://www.ahrq.gov/clinic/epcsums/samesum.htm
. Retrieved 8 Oct 2007
2. Akhondzadeh S, Kashani L, Mobaseri M, Hosseini SH, Nikzad S, Khani M (2001) Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial. J Clin Pharm Ther 26(5):369–373
3. Alpert JE, Papakostas G, Mischoulon D, Worthington JJ 3rd, Petersen T, Mahal Y, Burns A, Bottiglieri T, Nierenberg AA, Fava M (2004) S-adenosyl-l-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. J Clin Psychopharmacol 24(6):661–664
4. Altura BM, Altura BT (1999) Association of alcohol in brain injury, headaches, and stroke with brain-tissue and serum levels of ionized magnesium: a review of recent findings and mechanisms of action. Alcohol 19(2):119–130
5. Arciniegas DB (2003) The cholinergic hypothesis of cognitive impairment caused by traumatic brain injury. Curr Psychiatry Rev 5(5):391
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献